Health British Columbia

Cardiff Oncology announces $10M direct offering

Cardiff Oncology (CRDF) launches $10M registered direct offering with warrants, insider participation and July 16, 2026 close.

Cardiff Oncology announces $10M direct offering
Text to audio Audio version available

Cardiff Oncology (CRDF) launches $10M registered direct offering with warrants, insider participation and July 16, 2026 close.

Cardiff Oncology (CRDF) announced on Wednesday that it has entered into definitive agreements for the purchase and sale of 8.57M shares of its common stock and accompanying warrants to purchase up to an aggregate of 8.57M shares of its Cardiff Oncology (CRDF) announced on Wednesday that it has entered into definitive agreements for the purchase and sale of 8.57M shares of its common stock and accompanying warrants to purchase up to an aggregate of 8.57M shares of its

Published
Jul 15, 2026
Updated
Jul 15, 2026
Source
Seeking Alpha
Category
Health
Read time
1 min
Key facts

Key facts

SectionHealth
Open
SourceSeeking Alpha
Open
PublishedJul 15, 2026
UpdatedJul 15, 2026

Why this matters locally

This health story matters locally because it may affect readers, businesses, commuters, families, or public services in British Columbia.

Local impact

BC Post links this item to British Columbia coverage so readers can follow related city updates, weather, traffic, events, and category news in one place.

Timeline

PublishedJul 15, 2026, 5:13 AMThis story was published by BC Post.
ImportedJul 15, 2026, 10:15 AMThe item entered the BC Post source pipeline.
Transparency

Source and credit

BC Post may summarize, organize, and add local context for reader clarity. Original reporting remains with the listed publisher.

Seeking Alpha Published Jul 15, 2026 Imported Jul 15, 2026
Read Original Source
Seeking Alpha Jul 15, 2026
Read Original Source